Interventricular Electrical Delay Is Predictive of Response to Cardiac Resynchronization Therapy.

OBJECTIVES This study was conceived to evaluate the relationship between interventricular electrical delay, as measured by the right ventricle-left ventricle (RV-LV) interval, and outcomes in a prospectively designed substudy of the SMART-AV (SMARTDELAY determined AV Optimization) trial. BACKGROUND Despite the well-documented benefit of cardiac resynchronization therapy (CRT), the nonresponder rate remains an important clinical problem. Implanting LV leads by traditional anatomic criteria has limited impact on outcomes. However, pacing at sites with late electrical activation improves CRT response rates. Thus, we hypothesized that interventricular electrical delay is associated with improved CRT outcomes. METHODS This was a multicenter study of patients with advanced heart failure undergoing CRT implantation. In 419 subjects, the unpaced RV-LV interval was measured in sinus rhythm. LV volumes and ejection fraction were measured by echocardiography at baseline and after 6 months of CRT by a blinded core laboratory. Quality of life (QOL) was assessed by a standardized questionnaire. RESULTS When separated by quartiles based on interventricular delay, the magnitudes of LV volumes, ejection fraction and the QOL measure increased significantly with prolongation of RV-LV delay (p < 0.05). The LV end-systolic volume response rate increased progressively from 30% to 75% (p < 0.001), and the QOL response rate increased from 50% to 65% (p = 0.08). Patients in the highest quartile of RV-LV had a 5.98-fold increase (p < 0.001) in their odds of a reverse remodeling response, with female sex, ischemic etiology, and baseline LV end-systolic volume being the other independent predictors of response. CONCLUSIONS Baseline interventricular delay is a potent independent predictor of remodeling and QOL responses with CRT.

[1]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[2]  F. Ruschitzka The challenge of nonresponders to cardiac resynchronization therapy: lessons learned from oncology. , 2012, Heart rhythm.

[3]  Kenneth A. Ellenbogen,et al.  The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy , 2011, European heart journal.

[4]  M. Gold,et al.  The role of AV and VV optimization for CRT , 2013 .

[5]  Stefano Ghio,et al.  Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. , 2008, Journal of the American College of Cardiology.

[6]  D. Delurgio,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[7]  Thomas Guarnieri,et al.  Influence of Left Ventricular Lead Location on Outcomes in the COMPANION Study , 2009, Journal of cardiovascular electrophysiology.

[8]  Lluís Mont,et al.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.

[9]  M. Gold,et al.  SmartDelay Determined AV Optimization: A Comparison of AV Delay Methods Used in Cardiac Resynchronization Therapy (SMART‐AV): Rationale and Design , 2010, Pacing and clinical electrophysiology : PACE.

[10]  J. Nielsen,et al.  ESC Guidelines on cardiac pacing and cardiac resynchronization therapy , 2014 .

[11]  J. Daubert,et al.  Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. , 2001, The New England journal of medicine.

[12]  M. Gold,et al.  The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study. , 2015, Heart rhythm.

[13]  Wojciech Zareba,et al.  Left Ventricular Lead Position and Clinical Outcome in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) Trial , 2011, Circulation.

[14]  David Begley,et al.  Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. , 2012, Journal of the American College of Cardiology.

[15]  S. Barold,et al.  Value of right ventricular-left ventricular interlead electrical delay to predict reverse remodelling in cardiac resynchronization therapy: the INTER-V pilot study. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[16]  Jagmeet P. Singh,et al.  Electrical Delay in Apically Positioned Left Ventricular Leads and Clinical Outcome After Cardiac Resynchronization Therapy , 2013, Journal of cardiovascular electrophysiology.

[17]  Gianni Pastore,et al.  Determination of the Longest Intrapatient Left Ventricular Electrical Delay May Predict Acute Hemodynamic Improvement in Patients After Cardiac Resynchronization Therapy , 2014, Circulation. Arrhythmia and electrophysiology.

[18]  Mark A Hlatky,et al.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2013, Circulation.

[19]  Milton Packer,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[20]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[21]  Jeroen J. Bax,et al.  Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. , 2009, Journal of the American College of Cardiology.

[22]  Nicolas Derval,et al.  Noninvasive electrocardiographic mapping to improve patient selection for cardiac resynchronization therapy: beyond QRS duration and left bundle branch block morphology. , 2013, Journal of the American College of Cardiology.

[23]  M. Gold,et al.  The Effect of Left Ventricular Electrical Delay on the Acute Hemodynamic Response with Cardiac Resynchronization Therapy , 2014, Journal of cardiovascular electrophysiology.

[24]  Jagmeet P. Singh,et al.  The effect of left ventricular electrical delay on AV optimization for cardiac resynchronization therapy. , 2013, Heart rhythm.

[25]  Erwan Donal,et al.  Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial. , 2012, European heart journal.

[26]  Andrew P. Kramer,et al.  Transvenous biventricular pacing for heart failure: can the obstacles be overcome? , 1999, The American journal of cardiology.

[27]  S. Faerestrand,et al.  Clinical implication of right ventricular to left ventricular interlead sensed electrical delay in cardiac resynchronization therapy. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[28]  Suneet Mittal,et al.  Primary Results From the SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy (SMART-AV) Trial: A Randomized Trial Comparing Empirical, Echocardiography-Guided, and Algorithmic Atrioventricular Delay Programming in Cardiac Resynchron , 2010, Circulation.

[29]  M. Josephson,et al.  Endocardial activation of left bundle branch block. , 1984, Circulation.

[30]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[31]  Christophe Leclercq,et al.  2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. , 2012, Heart rhythm.

[32]  Role of intraoperative electrical parameters in predicting reverse remodelling after cardiac resynchronization therapy and correlation with interventricular mechanical dyssynchrony. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[33]  Jagmeet P. Singh,et al.  Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy. , 2006, Heart rhythm.

[34]  Luca Segreti,et al.  Superior vena cava defibrillator coils make transvenous lead extraction more challenging and riskier. , 2013, Journal of the American College of Cardiology.

[35]  S. Saba,et al.  Effect of echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy on mortality and risk of defibrillator therapy for ventricular arrhythmias in heart failure patients (from the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region [STARTER] tr , 2014, The American journal of cardiology.

[36]  Christophe Leclercq,et al.  2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.